There are critical gaps in our understanding of sex differences in Alzheimer’s disease (AD) including the higher prevalence of AD [1, 2], the steeper cognitive decline [3–5], and a stronger effect of the apolipoprotein E ε4 allele (APOE4) on AD risk in women versus men [6–8]. This evidence concerns the gene APOE and Alzheimer disease.